Deformation-based morphometry identifies deep brain structures protected by ocrelizumab

BACKGROUND: Despite advancements in treatments for multiple sclerosis, insidious disease progression remains an area of unmet medical need, for which atrophy-based biomarkers may help better characterize the progressive biology. METHODS: We developed and applied a method of longitudinal deformation-...

Descripción completa

Detalles Bibliográficos
Autores principales: Song, Zhuang, Krishnan, Anithapriya, Gaetano, Laura, Tustison, Nicholas J., Clayton, David, de Crespigny, Alex, Bengtsson, Thomas, Jia, Xiaoming, Carano, Richard A.D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Regular Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8861820/
https://www.ncbi.nlm.nih.gov/pubmed/35189455
http://dx.doi.org/10.1016/j.nicl.2022.102959

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8861820/
https://www.ncbi.nlm.nih.gov/pubmed/35189455
http://dx.doi.org/10.1016/j.nicl.2022.102959

Ejemplares similares